VIR

Vir Biotechnology, Inc.

Halal Rating :
Comfortable
See Details
Last Price $8.01 Last updated:
Market Cap $1.13b
7D Change -16.56%
1 Year Change -16.91%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Biological Products
  • Except Diagnostic Substances
Exchange NASDAQ
Next Earnings Date Oct. 31, 2024

Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. The company is headquartered in San Francisco, California.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $2.38m $233.68m - - 0.00% 0.00%
June 30, 2024 $3.08m $142.86m - $-18846000.0 0.00% 13.19%
March 31, 2024 $56.38m $136.46m - - 0.00% 0.00%

Company Impact

Help us evaluate Vir Biotechnology, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Justification for our Halal Rating

Contribute

Recent News & Updates